v3.24.2
Goodwill and Other Intangible Assets
 6 Months Ended
Jun. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets GOODWILL AND OTHER INTANGIBLE ASSETS
The following is a rollforward of the Company’s goodwill ($ in millions):
Balance, December 31, 2023$41,608 
Attributable to 2024 acquisition8 
Adjustments due to finalization of purchase price allocations(25)
Foreign currency translation and other(786)
Balance, June 28, 2024$40,805 
The carrying value of goodwill by segment is summarized as follows ($ in millions):
June 28, 2024December 31, 2023
Biotechnology$21,879 $22,477 
Life Sciences12,090 12,221 
Diagnostics6,836 6,910 
Total$40,805 $41,608 
The Company has not identified any “triggering” events which indicate an impairment of goodwill in 2024.
The Company reviews identified intangible assets for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. The Company has not identified impairment triggers which resulted in impairments of intangible assets in the second quarter of 2024. The Company identified impairment triggers in the second quarter of 2023 which resulted in impairment charges of certain long-lived assets, including technology and other assets. The Company recorded impairment charges totaling $28 million in the three and six-month periods ended June 30, 2023 related to these long-lived assets. In addition, during the three and six-month periods ended June 30, 2023, the Company recorded a $14 million impairment related to a facility.